Genetics of Response to ECT, TMS, Ketamine and Esketamine.

doi:10.1002/ajmg.b.33038

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Genetics of Response to ECT, TMS, Ketamine and Esketamine.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics - 1 Oct 2025

Franklin Clio E, Altinay Murat, Bailey Kala, Bhati Mahendra T, Carr Brent R, Conroy Susan K, Khurshid Khurshid, McDonald William M, Mickey Brian J, Murrough James W, Nestor Sean M, Nickl-Jockschat Thomas, Reti Irving M, Sanacora Gerard, Trapp Nicholas T, Viswanath Biju, Wright Jesse H, Zandi Peter P, Potash James B

Abstract excerpt

Treatment-resistant mood disorders are often managed with intensive interventions that include electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), ketamine, and esketamine, but the role of genetics in clinical response to those interventions is yet to be clearly determined. Here, we review the current literature on the genetics of response to these treatment modalities. To date, the limited...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain-Derived Neurotrophic Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Catechol O-Methyltransferase

Share to BDNF gene

Share to Genome-Wide Association Study

Share to Mood Disorders

Share to Polymorphism, Single Nucleotide

Share to Transcranial Magnetic Stimulation

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 40525674
DOI: 10.1002/ajmg.b.33038
PMCID: PMC12230785

Genes

BDNF
COMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetics of Response to ECT, TMS, Ketamine and Esketamine.PMID 40525674Read ↗

Pharmacogenetics of antidepressant response.Semantic proximity Read ↗

A Genetic Profile of Refractory Individuals with Major Depressive Disorder and Their Responsiveness to Transcranial Magnetic StimulationSemantic proximity Read ↗

Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits.Semantic proximity Read ↗

Pharmacogenetics of antidepressant response.Semantic proximity Read ↗

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.Semantic proximity Read ↗

Genome-wide association study of treatment resistant depression highlights shared biology with metabolic traitsSemantic proximity Read ↗

Genome-wide meta-analyses of non-response to antidepressants provide insights into underlying molecular genetics and suggest potential pharmacotherapies.Semantic proximity Read ↗

The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression.Semantic proximity Read ↗

Role of COMT, 5-HT(1A) , and SERT genetic polymorphisms on antidepressant response to Transcranial Magnetic Stimulation.Semantic proximity Read ↗

Role of the Pharmacogenomics in the Treatment-Resistant Depression: A Literature ReviewSemantic proximity Read ↗

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.Semantic proximity Read ↗

Genome-wide association studies of antidepressant outcome: a brief review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.